Evidence map›Paper›PMID 39269257›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

SKAP1 Expression in Cancer Cells Enhances Colon Tumor Growth and Impairs Cytotoxic Immunity by Promoting Neutrophil Extracellular Trap Formation via the NFATc1/CXCL8 Axis.

Jian Gao, Jun Liu, Jilin Lu, Xiaofei Zhang, Wei Zhang, Qian Li, Jiayi Cai, Mengjun Li, Yu Gan, Yifan Tang and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jian GaoState Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.ORCID 0000-0002-2830-4810
Jun LiuDepartment of General Surgery, Huashan Hospital (Hongqiao Campus), Fudan University, Shanghai, 201107, China.ORCID 0009-0009-8411-1931
Jilin LuDepartment of General Surgery, Huashan Hospital (Hongqiao Campus), Fudan University, Shanghai, 201107, China.
Xiaofei ZhangDepartment of General Surgery, Huashan Hospital (Hongqiao Campus), Fudan University, Shanghai, 201107, China.
Wei ZhangState Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
Qian LiState Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
Jiayi CaiClinical Research Unit, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Mengjun LiDepartment of General Surgery, Huashan Hospital (Hongqiao Campus), Fudan University, Shanghai, 201107, China.
Yu GanState Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.
Yifan TangDepartment of General Surgery, Huashan Hospital (Hongqiao Campus), Fudan University, Shanghai, 201107, China.
Shuangjie WuDepartment of General Surgery, Huashan Hospital (Hongqiao Campus), Fudan University, Shanghai, 201107, China.ORCID 0000-0001-8762-3822

Funding

National Natural Science Foundation of China 82073406National Natural Science Foundation of China 82103020National Natural Science Foundation of China 82203173Shanghai Municipal Health Commission 201640222
6 · The paper itself

Abstract

The mechanisms underlying the development and progression of colon cancer are not fully understood. Herein, Src kinase associated phosphoprotein 1 (SKAP1), an immune cell adaptor, is identified as a novel colon cancer-related gene. SKAP1 expression is significantly increased in colon cancer cells. High SKAP1 levels are independently predictive of poor survival in patients with colon cancer. Notably, SKAP1 expression in colon cancer cells exerted a significant tumor-promoting effect in vivo rather than in vitro. Screening of tumor-infiltrating immune cells revealed the involvement of neutrophils in SKAP1-induced colon tumor promotion. Enhanced formation of neutrophil extracellular traps (NETs) is found to be a key downstream event that contributed to the pro-tumor role of SKAP1. In colon cancer cells, SKAP1 increased the expression of C-X-C motif chemokine ligand 8 (CXCL8) via nuclear factor of activated T cells c1 (NFATc1). The blockade of CXCL8 or NFATc1 largely attenuated neutrophil infiltration, NET formation, and tumor promotion induced by SKAP1. Furthermore, inhibiting SKAP1-induced NET significantly enhanced the antitumor efficiency of adoptive natural killer cell therapy in colon tumor models. In conclusion, SKAP1 significantly promotes colon cancer growth via the cancer cell/neutrophil NFATc1/CXCL8/NET axis, suggesting that SKAP1 is a potential target for colon cancer therapy.

Indexed as

Colonic NeoplasmsExtracellular TrapsInterleukin-8NFATC Transcription FactorsAnimalsCell Line, TumorDisease Models, AnimalHumansMiceMice, Inbred BALB CNeutrophilsSignal TransductionCXCL8 protein, humanInterleukin-8NFATC1 protein, humanNFATC Transcription Factorscolon cancerCXCL8neutrophil extracellular trapNFATc1SKAP1

Identifiers

PMID39269257
PMCPMC11538704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.